TRADD Mediates RIPK1-Independent Necroptosis Induced by Tumor Necrosis Factor

As a programmed necrotic cell death, Necroptosis has the intrinsic initiators, including receptor-interacting serine/threonine-protein kinase 1 (RIPK1), RIPK3 and mixed-lineage kinase domain-like protein (MLKL), which combine to form necroptotic signaling pathway and mediate Necroptosis induced by various necroptotic stimuli, such as tumor necrosis factor (TNF). Although chemical inhibition of RIPK1 blocks TNF-induced Necroptosis, genetic elimination of RIPK1 does not suppress but facilitate Necroptosis triggered by TNF. Moreover, RIPK3 has been reported to mediate the RIPK1-independent Necroptosis, but the involved mechanism is unclear. In this study, we found that TRADD was essential for TNF-induced Necroptosis in RIPK1-knockdown L929 and HT-22 cells. Mechanistic study demonstrated that TRADD bound RIPK3 to form new protein complex, which then promoted RIPK3 phosphorylation via facilitating RIPK3 oligomerization, leading to RIPK3-MLKL signaling pathway activation. Therefore, TRADD acted as a partner of RIPK3 to initiate Necroptosis in RIPK1-knockdown L929 and HT-22 cells in response to TNF stimulation. In addition, TRADD was critical for the accumulation of Reactive Oxygen Species (ROS), which contributed to RIPK1-independent Necroptosis triggered by TNF. Collectively, our data demonstrate that TRADD acts as the new target protein for TNF-induced RIPK3 activation and the subsequent Necroptosis in a RIPK1-independent manner.